Procept Biorobotics (PRCT)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from PRCT's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Procept Biorobotics's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $34M | $75M | $136M | $224M | $308M |
| Net income | -$60M | -$87M | -$106M | -$91M | -$96M |
| Free cash flow | -$58M | -$83M | -$133M | -$104M | -$58M |
| EPS (diluted) | -$3.63 | -$1.96 | -$2.24 | -$1.75 | -$1.72 |
| Operating margin | -157.1% | -107.6% | -80.2% | -43.0% | -33.7% |
Where the revenue comes from
Revenue by regions, fiscal 2025. Every breakdown, year by year.
Superinvestors who own PRCT
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $8M | 0.00% | Q2 2026 |
Insider buying
Open-market purchases by Procept Biorobotics's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 9, 2026 | Antal Rohit Desai |
98,699 | $24.55 | $2M |
| Mar 6, 2026 | Antal Rohit Desai |
160,317 | $23.59 | $4M |
| Mar 5, 2026 | Antal Rohit Desai |
167,246 | $25.58 | $4M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when PRCT trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Procept Biorobotics insiders buying the stock?
3 open-market insider purchases of PRCT in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Procept Biorobotics?
1 of the superinvestors Investingly tracks hold PRCT in their latest 13F, including Cliff Asness.
Companies like Procept Biorobotics
All Healthcare stocks · Medical Devices stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.